Abstract
The growing prevalence of human monkeypox infection has developed an alarming situation worldwide. Monkeypox virus was first time found in 1958 in monkeys and later spread to humans. The first case of human monkeypox was reported in September 1970 in the Democratic Republic of the Congo. Human monkeypox was found outside Africa in the year 2003 in United States. More recently, from May 7 2022 to June 29, 2022, the monkeypox cases are swiftly spread worldwide, involving over 50 countries, and affecting 5115 people in Europe, the United Kingdom, North America, and South America, Asia, Australia, and the Middle East. The confirmed monkeypox cases in the United Kingdom from May 7, 2022 to June 29, 2022, are 1076 (21.03%); Germany 874 (17.08%); Spain 800 (15.64%); France 440 (8.60%); Portugal 391 (7.64%); United States 350 (6.84); Canada 276 (5.39%); Netherlands 257 (5.02%); Italy 159 (3.10); Belgium 117 (2.28%); Switzerland 81 (1.58%); Israel 33 (0.64%), and Ireland 31 (0.60%). However, in about 35 countries, the cases are less than 20 in each country. The epidemiological trends of the human monkeypox infection are swiftly shifting from endemic regions to non-endemic countries. The global health authorities must take priority-based preventive measures to stop the outbreaks of monkeypox disease across the globe.
Keywords: Human Monkeypox, Outbreak, Prevalence
INTRODUCTION
Monkeypox is a zoonotic disease, caused by a virus known as the monkeypox virus (MPXV). MPXV is a “double-stranded DNA virus” belonging to the genus Orthopoxvirus, subfamily Chordopoxvirinae and family poxviridae.1-4 Monkeypox was first found in 1958 after the occurrences of a pox-like disease in monkeys, hence the disease became popular with the name monkeypox. The first case of human monkeypox was reported in 1970 in the Democratic Republic of the Congo. After that, the disease has been found in other central and western African countries.1 More recently, since May 7, 2022, human monkeypox cases are reported in European countries, the United Kingdom, the United States, Australia, the Middle East and many other states worldwide.5,6
Biological characteristics
Monkeypox (MPX) virus has distinctive surface tubules and a dumbbell-shaped core component. The monkeypox virus is brick-shaped, with a size of approximately 200-250 nm. The virus is enclosed by a “lipoprotein envelope with a linear double-stranded DNA genome”.2,4 There are two distinct genetic clades of the monkeypox virus; the Central African clade “(Congo Basin clade)”, and “The West African Clade”. The Central African clade is a more transmissible and severe disease impact.5 The Central African clade is more deadly, with a case fatality rate of about 11% in the unvaccinated population, however, the West African clade has a better prognosis with less than 1% fatality rate. The Central African Clade originated from Gabon, Cameroon, Republic of Congo (ROC), Central African Republic (CAR), Sudan, and the Democratic Republic of Congo (DRC). West African clade originated from outbreaks in Nigeria, Liberia, Ivory Coast, Sierra Leone, and the USA (imported from Ghana) 1,5.
Transmission of monkeypox virus
MPXV can transmit from animal to animal, animal to human, and person to person. The virus can spread through direct contact with body fluids, cutaneous, mucosal lesions or sores on an infected person or with materials that have touched body fluids or sores, such as clothing or linens. It can also be spread by respiratory, oral, and nasal secretions, and during skin-to-skin, handshake, hugging, kissing, and sexual contact. The virus can cross the placenta from the mother to the fetus.7,8
Antinori et al., 20229, reported that the transmission of the infection is mainly through close contracts at home, office, community gatherings, healthcare workers, or sexual contacts. The authors further reported that the disease transmits on community contacts: household (23%), sexual (22%), friend/shared space (25%), workplace (23%), and community healthcare (7%). The literature suggests that transmission occurs through sexual contact. The authors further found four cases of young adult men in Italy, the seminal fluid samples were positive for monkeypox viral DNA. These reports further demonstrate that there is a high possibility of sexual transmission of the monkeypox virus.
Global Epidemiology of monkeypox disease
The first case of monkeypox was found in 1958 in monkeys after the occurrences of a pox-like disease in monkeys, hence the disease became popular with the name monkeypox. In the Democratic Republic of the Congo, the first human monkeypox case was reported in 1970. After that, the cases have been found in other central and western African countries.1 The literature highlights that “African rodents, squirrels, mice, rats, dogs, and monkeys are the natural reservoir and cause infections in humans”.10 There are two genetically clades, Congo Basin (Central African) clade more frequently occurred than the West African clade and caused human-to-human transmission.11,12
Human monkeypox cases have been reported outside of Africa in early 2000. In 2003, Gambian rats imported from Ghana infected 53 people with monkeypox in the Midwestern United States.12 In October 2018, a man was infected who travelled from Nigeria to Israel.13 In May 2019, another case travelled from Nigeria to Singapore.14 More recently, 2022. the world is witnessing the monkeypox virus causing a multi-country outbreak on almost all the continents outside Africa. 10,12
Since May 7, 2022, monkeypox cases have been reported in many European countries, the United Kingdom, the United States, Australia, the Middle East and other states in the world.5,6 The worldwide total number of confirmed and suspected cases of human monkeypox infection from 1970 to June 29, 2022, is 46,247 (Table-I). The number of confirmed cases of human monkeypox is 2805 and suspected cases are 38327. Among the confirmed cases 2,498 are of the Central African Clade, 307 are of the West African Clade (Table-I), and 5115 are in other 50 countries in Europe, the USA, the UK, and the Middle East and Australia (Table-II).4-6, 11-12
Table I.
| The time in decades/years | Central African Clade | West African Clade | Total |
|---|---|---|---|
| A: Confirmed cases | |||
| 1970-1979 | 38 | 9 | 47 |
| 1980-1989 | 355 | 1 | 356 |
| 1990-1999 | 520 | 0 | 520 |
| 2000-2009 | 92 | 47 | 139 |
| 2010-2019 | 85 | 195 | 280 |
| 2021 | -- | 34 | 34 |
| 2022 (Jan-June) | 1408 | 21 | 1429 |
| Confirmed Cases | 2498 | 307 | 2805 |
| B: Suspected Cases | |||
| 2000-2009 | 10,027 | -- | 10,027 |
| 2009-2019 | 18,788 | -- | 18788 |
| 2020 | 6,257 | -- | 3189 |
| 2021 | 3,091 | 98 | 66 |
| 2022 (Jan-June) | -- | 66 | 66 |
| Suspected Cases | 38,163 | 164 | 38,327 |
| Total Confirmed & Suspected Cases | 40,661 | 471 | 41,132 |
| C: Recent cases in Europe, UK, USA, Australia, Middle East | 5,115 | ||
|
| |||
| Grand Total cases | 46,247 | ||
Table II.
Monkeypox confirmed cases in Europe, UK, USA, Australia and the Middle East from May 7 to June 29, 2022.6 (n= number of countries).
| Country | Cases June 29 2022 (n=50) |
|---|---|
| United Kingdom | 1076 (21.03%) |
| Germany | 874 (17.08%) |
| Spain | 800 (15.64%) |
| France | 440 (8.60%) |
| Portugal | 391 (7.64%) |
| United States | 350 (6.84%) |
| Canada | 276 (5.39%) |
| Netherlands | 257 (5.02%) |
| Italy | 159 (3.10%) |
| Belgium | 117 (2.28%) |
| Switzerland | 81 (1.58%) |
| Israel | 33 (0.64%) |
| Ireland | 31 (0.60%) |
| Brazil | 21 (0.41%) |
| Austria | 20 (0.39%) |
| Denmark | 18 (0.35%) |
| Norway | 15 (0.29%) |
| Mexico | 15 (0.29%) |
| Sweden | 13 (0.25%) |
| United Arab Emirates | 13 (0.25%) |
| Hungary | 12 (0.23%) |
| Australia | 10 (0.19%) |
| Poland | 10 (0.19%) |
| Slovenia | 9 (0.17%) |
| Romania | 9 (0.17%) |
| Czechia | 8 (0.15%) |
| Slovenia | 7 (0.13%) |
| Chile | 6 (0.11%) |
| Finland | 4 (0.07%) |
| Argentina | 4 (0.07%) |
| Romania | 4 (0.07%) |
| Norway | 4 (0.07%) |
| Iceland | 4 (0.07%) |
| Greece | 3 (0.05%) |
| Benin | 3 (0.05%) |
| Colombia | 3 (0.05%) |
| Peru | 3 (0.05%) |
| Hungary | 3 (0.05%) |
| Bulgaria | 2 (0.03%) |
| Lativa | 2 (0.03%) |
| Morocco | 1 (0.01%) |
| Malta | 1 (0.01%) |
| Gibraltar | 1 (0.01%) |
| Venenzuela | 1 (0.01%) |
| Luxembourg | 1 (0.01%) |
| Bahamas | 1 (0.01%) |
| Croatia | 1 (0.01%) |
| Estonia | 1 (0.01%) |
| Georgia | 1 (0.01%) |
| Serbia | 1 (0.01%) |
| Singapore | 1 (0.01%) |
|
| |
| Total | 5115 |
Presently, monkeypox cases are swiftly spread and involved many countries worldwide. These cases are 5,115 which started in the United Kingdom on May 7, 2022, and spread over 50 countries in Europe, North America, South America, Asia, Australia, and the Middle East. The confirmed monkeypox cases in the United Kingdom from May 7, 2022 to June 29, 2022, are 1076 (21.03%); Germany 874 (17.08%); Spain 800 (15.64%); France 440 (8.60%); Portugal 391 (7.62%); United States 350 (6.84); Canada 276 (5.39%); Netherlands 257 (5.02%); Italy 159 (3.10); Belgium 117 (1.59%); Switzerland 81 (1.58%); Israel 33 (0.64%), Ireland, and 31 (0.64%) (Table II). However, in other countries, the cases reported are less than 25. The epidemiological trends of the human monkeypox virus are swiftly shifting from endemic regions to non-endemic countries.
Clinical Characteristics
Once the virus enters the body, replicates at the site and spreads to local lymph nodes. After that, viremia spread to body organs. This signifies the incubation period of 7-14 days with a maximum period of 21 days. The clinical features start with a secondary viremia leading to one to two days of prodromal clinical features such as fever and lymphadenopathy. The skin lesions start in the oropharynx and then appear in other parts of the body.15, 16 The “lesions begin as macules or papules, which progress to pustules and umbilicated vesicles and ulcers and eventually to crusted scabs”.17 The condition may establish differential diagnoses of the diseases including “syphilis, chancroid, varicella zoster, herpes simplex, hand-foot-and-mouth disease, and molluscum contagious”. The patients are infectious from the onset of symptoms until all scabs have been resolved.18
The common presenting symptoms include “fever, oral sores, swollen lymph nodes, and pain when swallowing”. The skin rashes “vesicular, pustular or ulcerated lesions sometimes appear first without spreading to other parts of the body” In some patients, pustules appear before the symptoms like fever.5 The clinical characteristics of “monkeypox” infection mostly consisted of mild symptoms, patients complained of headache, body ache, generalized myalgia, malaise and acute onset of fever. The skin lesions start as “macules or papules, which progress to pustules, umbilicated vesicles, ulcers and eventually to crusted scabs.11”
Diagnosis and Clinical Management
“Taking care of the patients with suspected or confirmed monkeypox requires early recognition through screening protocols adapted to local settings, prompt, isolation and rapid implementation of appropriate infection prevention and control (IPC). Measures.” As regards therapeutics, Tecorivimat is an antiviral drug which has recently been approved by the European Medicines Agency for orthopovirus-associated infections, including monkeypox. It is based on animal models and data for safety, pharmacokinetics and pharmacodynamics in humans. It is hoped that reliable and interpretable results on its safety and efficacy will be available soon.19
CONCLUSION
The epidemiological trends of the human monkeypox virus are swiftly shifting from endemic regions to non-endemic countries. Worldwide, the total number of confirmed and suspected cases of human monkeypox from 1970 to June 29, 2022, is 46,247. More recently, from May 7 2022 to June 29, 2022, the monkeypox cases are swiftly spread worldwide, involving over 50 countries, and affecting 5115 people in Europe, the United Kingdom, North America, and South America, Asia, Australia, and the Middle East. The transmission of diseases is mainly animal to human, and human to human. The major clinical characteristics of “monkeypox” infection are headache, body ache, generalized myalgia, malaise, acute onset of fever, swollen lymph nodes, and skin lesions. The skin lesion starts as macules or papules, progresses to pustules, vesicles and ulcers, and is ultimately converted into crusted scabs. The global health authorities must take priority-based preventive measures to stop the outbreaks of monkeypox disease across the globe. The education of the public, patients, and physicians is of the utmost importance to fight against monkeypox and stop it to become a pandemic.
Acknowledgements
We thank the “Researchers supporting project number (RSP-2021/47), King Saud University, Riyadh, Saudi Arabia”.
Footnotes
Conflicts of interest: None.
REFERENCES
- 1.Centres for Disease Control and Prevention (CDC) About Monkeypox. Available at: https://www.cdc.gov/poxvirus/monkeypox/about.html . (Cited date June 29,2022)
- 2.Kugelman JR, Johnston SC, Mulembakani PM, Kisalu N, Lee MS, Koroleva G, et al. Genomic variability of monkeypox virus among humans, the Democratic Republic of the Congo. Emerg Infect Dis. 2014;20(2):232–241. doi: 10.3201/eid2002.130118. doi:10.3201/eid2002.130118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Alakunle E, Moens U, Nchinda G, Okeke MI. Monkeypox Virus in Nigeria:Infection Biology, Epidemiology, and Evolution. Viruses. 2020;12(11):1257. doi: 10.3390/v12111257. doi:10.3390/v12111257. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Bunge EM, Hoet B, Chen L, Lienert F, Weidenthaler H, Baer LR, et al. The changing epidemiology of human monkeypox-A potential threat?A systematic review. PLoS Negl Trop Dis. 2022;16(2):e0010141. doi: 10.1371/journal.pntd.0010141. doi:10.1371/journal.pntd.0010141. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.World Health Organization (WHO) Multi-country monkeypox outbreak:situation update. 2022. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON390 . Cited date June 29.
- 6.Centres for Disease Control and Prevention (CDC) Monkeypox 2022 Monkeypox and Orthopoxvirus Outbreak Global Map. Available at: https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html . Cited date June 29,2022.
- 7.Centres for Disease Control and Prevention (CDC) Transmission. Available at: https://www.cdc.gov/poxvirus/monkeypox/transmission.html . Cited date June 17,2022.
- 8.Heskin J, Belfield A, Milne C, Brown N, Walters Y, Scott C, et al. Transmission of monkeypox virus through sexual contact - A novel route of infection. J Infect. 2022;22:S0163-4453 00335. doi: 10.1016/j.jinf.2022.05.028. doi:10.1016/j.jinf.2022.05.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Antinori A, Mazzotta V, Vita S, Carletti F, Tacconi D, Lapini LE, et al. Monkeypox Group Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022. Euro Surveill. 2022;27(22):2200421. doi: 10.2807/1560-7917.ES.2022.27.22.2200421. doi:10.2807/1560-7917. ES.2022.27. 22.2200421. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Sklenovská N, VanRanst M. Emergence of Monkeypox as the Most Important Orthopoxvirus Infection in Humans. Front Public Health. 2018;6:241. doi: 10.3389/fpubh.2018.00241. doi:10.3389/fpubh.2018.00241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.World Health Organizations Monkeypox Facts. Available at: https://www.who.int/news-room/fact-sheets/detail/monkeypox . Cited Date June 20,2022.
- 12.Centers for Disease Control and Prevention (CDC) Multistate outbreak of monkeypox--Illinois, Indiana, and Wisconsin,2003. Morb Mortal Wkly Rep. 2003;52(23):537–540. [PubMed] [Google Scholar]
- 13.Erez N, Achdout H, Milrot E, Schwartz Y, Well Y, Paran N, et al. Diagnosis of Imported Monkeypox, Israel, 2018. Emerg Infect Dis. 2019;25(5):980–983. doi: 10.3201/eid2505.190076. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Yong SEF, Ng OT, Ho ZJM, Mak TM, Marimuthu K, Vasoo S, et al. Imported Monkeypox, Singapore. Emerg Infect Dis. 2020;26(8):1826–1830. doi: 10.3201/eid2608.191387. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Moore M, Zahra F. Monkeypox. Available at: https:// www.ncbi.nlm.nih.gov/books/NBK574519/Table . Cited date June 18,2022.
- 16.Figueroa LDA, Aldana BDK, Pachar M, Romaní L, Cumpa SHM, Zuloeta AC, et al. The never ending global emergence of viral zoonoses after COVID-19?The rising concern of monkeypox in Europe, North America and beyond. Travel Med Infect Dis. 2022;49:102362. doi: 10.1016/j.tmaid.2022.102362. doi:10.1016/j.tmaid.2022.102362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Hutson CL, Carroll DS, Romero GN, Drew C, Zaki SR, Nagy T, et al. Comparison of Monkeypox Virus Clade Kinetics and Pathology within the Prairie Dog Animal Model Using a Serial Sacrifice Study Design. Biomed Res Int. 2015;2015:965710. doi: 10.1155/2015/965710. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Halani S, Mishra S, Bogoch II. The monkeypox virus. CMAJ. 2022;194(24):844. doi: 10.1503/cmaj.220795. doi:10.1503/cmaj.220795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Multi-country monkeypox outbreak:Situation update by WHO. 2022. [Accessed on June 27,]. Available at: https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON396 .
